PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.\', \'Mynvax Private Limited, ES12, Entrepreneurship Centre, Society for Innovation and Development (SID), Indian Institute of Science, Bengaluru, India.\', \'Virology Unit, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Chandigarh, India.\', \'Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), Geelong, VIC, Australia.\', \'Max Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare, Delhi, India.\', \'INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.\', \'Department of Microbiology & Cell Biology, Indian Institute of Science, Bengaluru, India.\', \'Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India.\', \'Department of Health Sciences, University of York, York, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.765211
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34956193
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all